A Agilent Technologies | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $130.41 -0.8% | $135.00 ➝ $125.00 | Underweight ➝ Underweight | |
AAL American Airlines Group | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.50 +0.5% | $20.00 ➝ $16.50 | Buy ➝ Buy | |
ABL Abacus Life | Initiated by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.41 +13.5% | $16.00 | Buy | |
ACIU AC Immune | Initiated by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.65 +17.1% | $8.00 | Buy | |
ACLX Arcellx | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Amin Subscribe to MarketBeat All Access for the recommendation accuracy rating | $52.00 -0.5% | $70.00 | Overweight | |
ADC Agree Realty | Initiated by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $60.76 +0.8% | $60.00 | Neutral | |
|
ADUS Addus HomeCare | Target Raised by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $114.81 +2.8% | $120.00 ➝ $128.00 | Overweight ➝ Overweight | |
AGO Assured Guaranty | Target Lowered by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $77.72 +1.0% | $92.00 ➝ $87.00 | Market Perform ➝ Market Perform | |
ALLO Allogene Therapeutics | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.50 +1.6% | $11.00 | Overweight | |
AMBA Ambarella | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.26 +20.6% | $90.00 ➝ $90.00 | Buy ➝ Buy | |
AMBA Ambarella | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.26 +20.6% | $57.00 ➝ $67.00 | Overweight ➝ Overweight | |
AMBA Ambarella | Target Lowered by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.26 +20.6% | $65.00 ➝ $60.00 | Neutral ➝ Neutral | |
AMBA Ambarella | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.26 +20.6% | $65.00 ➝ $55.00 | Equal Weight ➝ Equal Weight | |
AMSC American Superconductor | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.18 +10.0% | $16.00 ➝ $23.00 | Outperform ➝ Outperform | |
AMSC American Superconductor | Target Raised by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.18 +10.0% | $16.00 ➝ $23.00 | Buy ➝ Buy | |
AMSC American Superconductor | Target Raised by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.18 +10.0% | $15.00 ➝ $20.00 | Buy ➝ Buy | |
APD Air Products and Chemicals | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $266.70 +2.4% | $263.00 ➝ $276.00 | Outperform ➝ Outperform | |
APLS Apellis Pharmaceuticals | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Amin Subscribe to MarketBeat All Access for the recommendation accuracy rating | $39.25 -3.7% | $46.00 | Neutral | |
ASAN Asana | Target Lowered by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.05 -0.6% | $17.00 ➝ $16.00 | Hold ➝ Hold | |
ASAN Asana | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.05 -0.6% | $27.00 ➝ $27.00 | Market Outperform ➝ Market Outperform | |
ASAN Asana | Target Lowered by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.05 -0.6% | $28.00 ➝ $23.00 | Outperform ➝ Outperform | |
ASAN Asana | Target Lowered by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.05 -0.6% | $14.00 ➝ $13.00 | Underweight ➝ Underweight | |
ASAN Asana | Upgraded by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.05 -0.6% | $18.00 ➝ $16.00 | Underweight ➝ Neutral | |
ASND Ascendis Pharma A/S | Initiated by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $135.10 -1.7% | $200.00 | Buy | |
AVB AvalonBay Communities | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $192.68 +1.4% | $189.00 ➝ $210.00 | Overweight ➝ Overweight | |
BBY Best Buy | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.82 +4.0% | $80.00 ➝ $90.00 | In-Line ➝ In-Line | |
BBY Best Buy | Target Raised by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.82 +4.0% | $90.00 ➝ $95.00 | Buy ➝ Buy | |
BBY Best Buy | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.82 +4.0% | $87.00 ➝ $86.00 | Hold ➝ Hold | |
BHP BHP Group | Initiated by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $59.53 +1.5% | | Buy ➝ Buy | |
BILI Bilibili | Upgraded by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.52 +0.7% | $11.90 ➝ $18.00 | Neutral ➝ Buy | |
BILL BILL | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.05 +1.5% | $74.00 ➝ $60.00 | Neutral ➝ Neutral | |
BIRK Birkenstock | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.00 +2.1% | $54.00 ➝ $62.00 | Neutral ➝ Neutral | |
BIRK Birkenstock | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.00 +2.1% | $58.00 ➝ $65.00 | Outperform ➝ Outperform | |
BIRK Birkenstock | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.00 +2.1% | $54.00 ➝ $60.00 | Outperform ➝ Outperform | |
BIRK Birkenstock | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.00 +2.1% | $54.00 ➝ $63.00 | Outperform ➝ Outperform | |
BIRK Birkenstock | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.00 +2.1% | $54.00 ➝ $63.00 | Buy ➝ Buy | |
BRO Brown & Brown | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $89.51 +2.0% | $94.00 ➝ $100.00 | Buy ➝ Buy | |
BRZE Braze | Target Lowered by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.65 +0.9% | $68.00 ➝ $62.00 | Buy ➝ Buy | |
BRZE Braze | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.65 +0.9% | $65.00 ➝ $52.00 | Buy ➝ Buy | |
BURL Burlington Stores | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $240.05 +1.9% | $227.00 ➝ $240.00 | Outperform ➝ Outperform | |
Nvidia is Pivoting to Solve Big Tech’s $1 Trillion Problem (Ad) Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%.
Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …![](gif/triggeredcampaignpixelff2e.gif?TriggeredCampaignID=8054&Placement=NativeDisplay&Source=NativeDisplay) Find out details on these three critical Nvidia partners immediately. |
BURL Burlington Stores | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $240.05 +1.9% | $250.00 ➝ $274.00 | Outperform ➝ Outperform | |
BURL Burlington Stores | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $240.05 +1.9% | $240.00 ➝ $275.00 | Overweight ➝ Overweight | |
BURL Burlington Stores | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $240.05 +1.9% | $252.00 ➝ $274.00 | Overweight ➝ Overweight | |
BURL Burlington Stores | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $240.05 +1.9% | $209.00 ➝ $257.00 | Hold ➝ Hold | |
BURL Burlington Stores | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $240.05 +1.9% | $246.00 ➝ $284.00 | Overweight ➝ Overweight | |
BURL Burlington Stores | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $240.05 +1.9% | $260.00 ➝ $275.00 | Outperform ➝ Outperform | |
BURL Burlington Stores | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $240.05 +1.9% | $250.00 ➝ $275.00 | Buy ➝ Buy | |
BURL Burlington Stores | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $240.05 +1.9% | $258.00 ➝ $276.00 | Buy ➝ Buy | |
BZH Beazer Homes USA | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.72 +4.5% | $37.00 | Outperform | |
CALT Calliditas Therapeutics AB (publ) | Reiterated by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.99 +4.0% | $39.00 | Buy ➝ Neutral | |
CBRL Cracker Barrel Old Country Store | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $48.78 +1.4% | $48.00 ➝ $42.00 | Sell ➝ Sell | |
CBRL Cracker Barrel Old Country Store | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $48.78 +1.4% | $51.00 ➝ $46.00 | Hold ➝ Hold | |
CCS Century Communities | Upgraded by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Mccanless Subscribe to MarketBeat All Access for the recommendation accuracy rating | $84.41 +1.6% | $82.00 | Underperform ➝ Neutral | |
CDNA CareDx | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.01 -3.8% | | Neutral | |
CELC Celcuity | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.80 +4.6% | $24.00 ➝ $23.00 | Buy ➝ Buy | |
CHWY Chewy | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.21 -1.5% | $19.00 ➝ $22.00 | In-Line ➝ In-Line | |
CLLS Cellectis | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.71 -0.1% | $6.00 ➝ $6.00 | Market Outperform ➝ Market Outperform | |
CM Canadian Imperial Bank of Commerce | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.54 -2.1% | $74.00 ➝ $77.00 | Outperform ➝ Outperform | |
CNOB ConnectOne Bancorp | Reiterated by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Switzer Subscribe to MarketBeat All Access for the recommendation accuracy rating | $18.64 -1.4% | $24.00 ➝ $22.00 | Outperform ➝ Market Perform | |
COO Cooper Companies | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.31 +4.5% | | Hold | |
COO Cooper Companies | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.31 +4.5% | $116.00 ➝ $118.00 | Outperform ➝ Outperform | |
COST Costco Wholesale | Target Raised by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $809.89 -0.7% | $800.00 ➝ $850.00 | Outperform ➝ Outperform | |
COST Costco Wholesale | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $809.89 -0.7% | $650.00 ➝ $676.00 | Neutral ➝ Neutral | |
COST Costco Wholesale | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $809.89 -0.7% | $750.00 ➝ $775.00 | Equal Weight ➝ Equal Weight | |
COST Costco Wholesale | Reiterated by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $809.89 -0.7% | $800.00 ➝ $875.00 | Outperform ➝ Outperform | |
COST Costco Wholesale | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $809.89 -0.7% | $777.00 ➝ $850.00 | Buy ➝ Buy | |
COST Costco Wholesale | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $809.89 -0.7% | $700.00 ➝ $765.00 | Equal Weight ➝ Equal Weight | |
COST Costco Wholesale | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $809.89 -0.7% | $815.00 ➝ $873.00 | Buy ➝ Buy | |
COST Costco Wholesale | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $809.89 -0.7% | $845.00 ➝ $860.00 | Outperform ➝ Outperform | |
COST Costco Wholesale | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $809.89 -0.7% | $800.00 ➝ $850.00 | Buy ➝ Buy | |
COST Costco Wholesale | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $809.89 -0.7% | $710.00 ➝ $800.00 | Neutral ➝ Neutral | |
CPT Camden Property Trust | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $102.65 +1.6% | $92.00 ➝ $104.00 | Underweight ➝ Underweight | |
CRM Salesforce | Target Lowered by | Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $234.44 +7.5% | $330.00 ➝ $275.00 | Outperform ➝ Outperform | |
CTXR Citius Pharmaceuticals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.70 +6.4% | $4.00 ➝ $4.00 | Buy ➝ Buy | |
CYTH Cyclo Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Ramakanth Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.28 -1.5% | $3.00 ➝ $3.00 | Buy ➝ Buy | |
DELL Dell Technologies | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $139.56 -17.9% | $98.00 ➝ $97.00 | Underweight ➝ Underweight | |
DELL Dell Technologies | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $139.56 -17.9% | $170.00 ➝ $175.00 | Overweight ➝ Overweight | |
DELL Dell Technologies | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $139.56 -17.9% | $152.00 ➝ $155.00 | Overweight ➝ Overweight | |
DELL Dell Technologies | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $139.56 -17.9% | $105.00 ➝ $155.00 | Hold ➝ Hold | |
DG Dollar General | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $136.91 +7.0% | $147.00 ➝ $141.00 | Neutral ➝ Neutral | |
DG Dollar General | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $136.91 +7.0% | $140.00 ➝ $135.00 | Hold ➝ Hold | |
DG Dollar General | Target Lowered by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $136.91 +7.0% | $161.00 ➝ $137.00 | Neutral ➝ Neutral | |
DG Dollar General | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $136.91 +7.0% | $150.00 ➝ $140.00 | Market Perform ➝ Market Perform | |
DG Dollar General | Target Lowered by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $136.91 +7.0% | $150.00 ➝ $135.00 | Hold ➝ Hold | |
DGHI Digihost Technology | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.32 +3.9% | $2.50 ➝ $2.50 | Buy ➝ Buy | |
DLTH Duluth | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.95 -0.3% | $5.00 ➝ $4.50 | Neutral ➝ Neutral | |
DLTR Dollar Tree | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $117.95 +2.8% | $160.00 ➝ $160.00 | Outperform ➝ Outperform | |
DSGX The Descartes Systems Group | Target Raised by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.33 +1.5% | $94.00 ➝ $96.00 | Market Perform ➝ Market Perform | |
DSGX The Descartes Systems Group | Target Raised by | Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.33 +1.5% | $100.00 ➝ $104.00 | Sector Outperform ➝ Sector Outperform | |
DXLG Destination XL Group | Target Lowered by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.55 +7.6% | $3.50 ➝ $3.00 | Hold ➝ Hold | |
Next President (Not Trump. Not Biden.) (Ad) Do you want to see who I believe will be the next president of the U.S.A?
It won’t be Biden…And it won’t be Trump.![](gif/triggeredcampaignpixel806f.gif?TriggeredCampaignID=8088&Placement=NativeDisplay&Source=NativeDisplay) Click here to see why it will be ______ _________. |
DY Dycom Industries | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Rygiel Subscribe to MarketBeat All Access for the recommendation accuracy rating | $179.96 -2.4% | $172.00 ➝ $205.00 | Buy ➝ Buy | |
EGP EastGroup Properties | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $165.18 +2.7% | $185.00 ➝ $175.00 | Neutral ➝ Neutral | |
ELEV Elevation Oncology | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Amin Subscribe to MarketBeat All Access for the recommendation accuracy rating | $4.02 -1.2% | $10.00 | Overweight | |
ENPH Enphase Energy | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $127.90 -2.1% | $130.00 ➝ $150.00 | Buy ➝ Buy | |
EPRT Essential Properties Realty Trust | Initiated by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.78 +1.2% | $30.00 | Buy | |
EQR Equity Residential | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.03 +1.8% | $66.00 ➝ $69.00 | Overweight ➝ Overweight | |
ESS Essex Property Trust | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $259.79 +1.6% | $232.00 ➝ $269.00 | Equal Weight ➝ Equal Weight | |
ESTC Elastic | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $104.05 +11.7% | $128.00 ➝ $117.00 | Equal Weight ➝ Equal Weight | |
ESTC Elastic | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $104.05 +11.7% | $130.00 ➝ $125.00 | Buy ➝ Buy | |
ESTC Elastic | Target Lowered by | Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $104.05 +11.7% | $154.00 ➝ $135.00 | Sector Outperform ➝ Sector Outperform | |
ESTC Elastic | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $104.05 +11.7% | $130.00 ➝ $120.00 | Buy ➝ Buy | |
ESTC Elastic | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $104.05 +11.7% | $150.00 ➝ $140.00 | Buy ➝ Buy | |
ESTC Elastic | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $104.05 +11.7% | | Hold | |
ETR Entergy | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $112.49 +4.4% | $107.00 ➝ $114.00 | Buy ➝ Buy | |
FITB Fifth Third Bancorp | Upgraded by | Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.42 +1.8% | $43.00 | Peer Perform ➝ Outperform | |
FIVE Five Below | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $138.13 +2.5% | $220.00 ➝ $220.00 | Outperform ➝ Outperform | |
FL Foot Locker | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.73 +7.1% | $20.00 ➝ $24.00 | Equal Weight ➝ Equal Weight | |
FL Foot Locker | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.73 +7.1% | $22.00 ➝ $27.00 | Equal Weight ➝ Equal Weight | |
FSLR First Solar | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $271.76 -1.8% | $230.00 ➝ $320.00 | Buy ➝ Buy | |
FSS Federal Signal | Initiated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.02 +5.5% | | Outperform | |
FTAI FTAI Aviation | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $84.32 +3.7% | $100.00 ➝ $100.00 | Buy ➝ Buy | |
GABC German American Bancorp | Target Raised by | Hovde Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.65 -0.8% | $33.00 ➝ $34.00 | Market Perform | |
GDDY GoDaddy | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $139.63 +1.0% | $150.00 ➝ $165.00 | Buy ➝ Buy | |
GNLX Genelux | Target Lowered by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.71 +2.3% | $30.00 ➝ $25.00 | Speculative Buy ➝ Speculative Buy | |
GPS GAP | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.96 +28.6% | $18.00 ➝ $23.00 | Market Perform ➝ Market Perform | |
GPS GAP | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.96 +28.6% | $24.00 ➝ $32.00 | Outperform ➝ Outperform | |
GPS GAP | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.96 +28.6% | $20.00 ➝ $27.00 | Neutral ➝ Neutral | |
GPS GAP | Target Raised by | Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.96 +28.6% | $17.00 ➝ $28.00 | Hold ➝ Hold | |
GPS GAP | Target Raised by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.96 +28.6% | $22.00 ➝ $29.00 | Market Perform ➝ Market Perform | |
GPS GAP | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.96 +28.6% | $20.00 ➝ $27.00 | Equal Weight ➝ Equal Weight | |
GPS GAP | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.96 +28.6% | $23.00 ➝ $28.00 | Neutral ➝ Neutral | |
GPS GAP | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.96 +28.6% | $15.50 ➝ $18.50 | Underperform ➝ Underperform | |
GREE Greenidge Generation | Target Lowered by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.62 -7.7% | $6.00 ➝ $5.00 | Buy ➝ Buy | |
HRL Hormel Foods | Upgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.98 +0.6% | $28.00 ➝ $29.00 | Underweight ➝ Neutral | |
HRL Hormel Foods | Reiterated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.98 +0.6% | $32.00 ➝ $32.00 | Equal Weight ➝ Equal Weight | |
HRL Hormel Foods | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.98 +0.6% | $35.00 ➝ $33.00 | Neutral ➝ Neutral | |
HTLF Heartland Financial USA | Upgraded by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Delmonte Subscribe to MarketBeat All Access for the recommendation accuracy rating | $43.96 +2.1% | $51.00 ➝ $54.00 | Market Perform ➝ Outperform | |
HWC Hancock Whitney | Upgraded by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Mealor Subscribe to MarketBeat All Access for the recommendation accuracy rating | $46.73 +1.6% | $50.00 ➝ $55.00 | Market Perform ➝ Outperform | |
IBTX Independent Bank Group | Upgraded by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $46.04 +0.1% | $38.00 ➝ $58.00 | Underweight ➝ Overweight | |
ICFI ICF International | Reiterated by | Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $142.75 +2.4% | $173.00 ➝ $173.00 | Outperform ➝ Outperform | |
ICLR ICON Public | Reiterated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $324.82 +0.6% | | Outperform | |
ICLR ICON Public | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $324.82 +0.6% | $363.00 ➝ $367.00 | Outperform ➝ Outperform | |
ICLR ICON Public | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $324.82 +0.6% | $349.00 ➝ $373.00 | Buy ➝ Buy | |
IMNM Immunome | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Amin Subscribe to MarketBeat All Access for the recommendation accuracy rating | $14.94 +1.6% | $27.00 | Overweight | |
INSM Insmed | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.05 -3.4% | $39.00 ➝ $67.00 | Buy ➝ Buy | |
IOVA Iovance Biotherapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.88 -1.3% | $32.00 ➝ $32.00 | Buy ➝ Buy | |
ITRM Iterum Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | E. Arce Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.50 +16.3% | $6.00 ➝ $6.00 | Buy ➝ Buy | |
JWN Nordstrom | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.10 +5.1% | $15.00 ➝ $18.00 | Underperform ➝ Underperform | |
JWN Nordstrom | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.10 +5.1% | $19.00 ➝ $19.00 | Market Perform ➝ Market Perform | |
JWN Nordstrom | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.10 +5.1% | $17.00 ➝ $19.00 | In-Line ➝ In-Line | |
The Only Energy Play You Should Be Looking At (Ad) Open AI’s Sam Altman recently helped this company raise $577 million in funding…
What’s more is, It has already inked deals with the Department of Energy.![](gif/triggeredcampaignpixel5523.gif?TriggeredCampaignID=8190&Placement=NativeDisplay&Source=NativeDisplay) Click here to get all the information about it. |
JWN Nordstrom | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.10 +5.1% | $15.00 ➝ $18.00 | Underweight ➝ Underweight | |
KSS Kohl's | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.39 +6.5% | $24.00 ➝ $22.00 | In-Line ➝ In-Line | |
KSS Kohl's | Target Lowered by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.39 +6.5% | $25.00 ➝ $20.00 | Neutral ➝ Neutral | |
KSS Kohl's | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.39 +6.5% | $31.00 ➝ $25.00 | Buy ➝ Buy | |
KSS Kohl's | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.39 +6.5% | $32.00 ➝ $27.00 | Outperform ➝ Outperform | |
LMAT LeMaitre Vascular | Reiterated by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $78.88 +0.1% | $100.00 | Buy | |
LMAT LeMaitre Vascular | Upgraded by | Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Wittes Subscribe to MarketBeat All Access for the recommendation accuracy rating | $78.88 +0.1% | | Strong-Buy | |
LRMR Larimar Therapeutics | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.00 +12.7% | $25.00 ➝ $25.00 | Market Outperform ➝ Market Outperform | |
LSEA Landsea Homes | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.92 +2.1% | $14.00 | Outperform | |
MAA Mid-America Apartment Communities | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $133.71 +3.0% | $129.00 ➝ $138.00 | Equal Weight ➝ Equal Weight | |
MAXN Maxeon Solar Technologies | Downgraded by | Northland Capmk Subscribe to MarketBeat All Access for the recommendation accuracy rating | D. Schafer Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.88 -7.4% | | Hold ➝ Strong Sell | |
MAXN Maxeon Solar Technologies | Target Lowered by | Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.88 -7.4% | $3.00 ➝ $2.00 | Neutral ➝ Neutral | |
MAXN Maxeon Solar Technologies | Downgraded by | Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.88 -7.4% | $7.00 ➝ $0.50 | Market Perform ➝ Under Perform | |
MBI MBIA | Target Lowered by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.65 -0.9% | $7.50 ➝ $6.50 | Market Perform ➝ Market Perform | |
MDB MongoDB | Upgraded by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Kessinger Subscribe to MarketBeat All Access for the recommendation accuracy rating | $236.06 -23.9% | | Hold ➝ Strong-Buy | |
MDB MongoDB | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $458.00 ➝ $290.00 | Overweight ➝ Overweight | |
MDB MongoDB | Target Lowered by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $415.00 ➝ $315.00 | Buy ➝ Buy | |
MDB MongoDB | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $435.00 ➝ $300.00 | Buy ➝ Buy | |
MDB MongoDB | Target Lowered by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $480.00 ➝ $300.00 | Outperform ➝ Outperform | |
MDB MongoDB | Target Lowered by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $440.00 ➝ $380.00 | Market Outperform ➝ Market Outperform | |
MDB MongoDB | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $435.00 ➝ $325.00 | Buy ➝ Buy | |
MDB MongoDB | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $450.00 ➝ $300.00 | Overweight ➝ Overweight | |
MDB MongoDB | Target Lowered by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $465.00 ➝ $290.00 | Buy ➝ Buy | |
MDB MongoDB | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $480.00 ➝ $350.00 | Overweight ➝ Overweight | |
MDB MongoDB | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $455.00 ➝ $320.00 | Overweight ➝ Overweight | |
MDB MongoDB | Target Lowered by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $450.00 ➝ $305.00 | Outperform ➝ Outperform | |
MDB MongoDB | Target Lowered by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $475.00 ➝ $300.00 | Buy ➝ Buy | |
MDB MongoDB | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $236.06 -23.9% | $380.00 ➝ $250.00 | Neutral ➝ Neutral | |
MFA MFA Financial | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.70 +1.5% | $12.50 ➝ $12.50 | Market Outperform ➝ Market Outperform | |
MGY Magnolia Oil & Gas | Target Raised by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.95 +1.9% | $33.00 ➝ $35.00 | Buy ➝ Buy | |
MOV Movado Group | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.50 +0.8% | $41.00 ➝ $41.00 | Buy ➝ Buy | |
MRO Marathon Oil | Reiterated by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.96 +2.7% | $38.00 ➝ $29.00 | Overweight ➝ Equal Weight | |
MRVL Marvell Technology | Target Raised by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $68.81 -10.5% | $71.00 ➝ $77.00 | Equal Weight ➝ Equal Weight | |
MRVL Marvell Technology | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $68.81 -10.5% | $95.00 ➝ $95.00 | Buy ➝ Buy | |
MRVL Marvell Technology | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $68.81 -10.5% | $75.00 ➝ $80.00 | Overweight ➝ Overweight | |
MRVL Marvell Technology | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $68.81 -10.5% | $80.00 ➝ $90.00 | Outperform ➝ Outperform | |
MRVL Marvell Technology | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Muse Subscribe to MarketBeat All Access for the recommendation accuracy rating | $68.81 -10.5% | $85.00 ➝ $85.00 | Overweight ➝ Overweight | |
MRVL Marvell Technology | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $68.81 -10.5% | $86.00 ➝ $90.00 | Buy ➝ Buy | |
MRVL Marvell Technology | Target Raised by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $68.81 -10.5% | $88.00 ➝ $91.00 | Outperform ➝ Outperform | |
MRVL Marvell Technology | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $68.81 -10.5% | $95.00 ➝ $100.00 | Buy ➝ Buy | |
MTZ MasTec | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $112.25 +0.8% | $120.00 ➝ $132.00 | Buy ➝ Buy | |
MU Micron Technology | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $125.00 -1.0% | $150.00 ➝ $155.00 | Buy ➝ Buy | |
NET Cloudflare | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $67.69 -0.4% | $135.00 ➝ $135.00 | Buy ➝ Buy | |
NET Cloudflare | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | Y. Lee Subscribe to MarketBeat All Access for the recommendation accuracy rating | $67.69 -0.4% | $80.00 ➝ $80.00 | Neutral ➝ Neutral | |
NET Cloudflare | Target Lowered by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $67.69 -0.4% | $108.00 ➝ $90.00 | Outperform ➝ Outperform | |
NGD New Gold | Initiated by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.19 -0.5% | $3.00 ➝ $3.50 | Outperform ➝ Outperform | |
NNN NNN REIT | Initiated by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.77 +2.0% | $41.00 | Neutral | |
NTAP NetApp | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.43 +3.4% | $100.00 ➝ $116.00 | Equal Weight ➝ Equal Weight | |
NTAP NetApp | Target Raised by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.43 +3.4% | $120.00 ➝ $135.00 | Buy ➝ Buy | |
NTAP NetApp | Upgraded by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.43 +3.4% | $95.00 ➝ $125.00 | Underweight ➝ Neutral | |
Are You Positioned For The New Energy Goldrush? (Ad) Open AI’s Sam Altman recently helped this company raise $577 million in funding…
What’s more is, It has already inked deals with the Department of Energy.![](gif/triggeredcampaignpixel4b64.gif?TriggeredCampaignID=8003&Placement=NativeDisplay&Source=NativeDisplay) Click here to get all the information about it. |
NTAP NetApp | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.43 +3.4% | $120.00 ➝ $130.00 | Buy ➝ Buy | |
NTAP NetApp | Target Raised by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.43 +3.4% | $130.00 ➝ $138.00 | Positive ➝ Positive | |
NTAP NetApp | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.43 +3.4% | $100.00 ➝ $120.00 | Equal Weight ➝ Equal Weight | |
NXTC NextCure | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.54 -2.5% | $8.00 ➝ $8.00 | Buy ➝ Buy | |
O Realty Income | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.06 +2.5% | $67.00 ➝ $61.00 | Buy ➝ Buy | |
OCFC OceanFirst Financial | Reiterated by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Switzer Subscribe to MarketBeat All Access for the recommendation accuracy rating | $15.05 +2.9% | $19.00 ➝ $18.00 | Outperform ➝ Market Perform | |
OCUL Ocular Therapeutix | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.70 -1.7% | $15.00 | Overweight | |
ONCT Oncternal Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.21 +1.2% | $19.00 ➝ $19.00 | Buy ➝ Buy | |
PATH UiPath | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.26 +1.6% | $30.00 ➝ $19.00 | Buy ➝ Buy | |
PD PagerDuty | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.97 +5.7% | $27.00 ➝ $26.00 | Buy ➝ Buy | |
PENN PENN Entertainment | Target Lowered by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.50 +19.6% | $27.00 ➝ $26.00 | Positive ➝ Positive | |
PHAR Pharming Group | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.15 +2.5% | $37.00 ➝ $37.00 | Buy ➝ Buy | |
PHAT Phathom Pharmaceuticals | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.42 -7.6% | $26.00 ➝ $26.00 | Buy ➝ Buy | |
PHR Phreesia | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.92 -11.2% | $37.00 ➝ $34.00 | Buy ➝ Buy | |
PHR Phreesia | Reiterated by | Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.92 -11.2% | $28.00 ➝ $28.00 | Overweight ➝ Overweight | |
PHR Phreesia | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.92 -11.2% | $30.00 ➝ $30.00 | Market Outperform ➝ Market Outperform | |
PHR Phreesia | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.92 -11.2% | $29.00 ➝ $29.00 | Buy ➝ Buy | |
PLD Prologis | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $110.49 +2.7% | $130.00 ➝ $120.00 | Neutral ➝ Neutral | |
PYPL PayPal | Initiated by | New Street Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.99 +0.8% | $80.00 | Buy | |
QCOM QUALCOMM | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $204.05 -0.4% | $180.00 ➝ $240.00 | Buy ➝ Buy | |
QCOM QUALCOMM | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $204.05 -0.4% | $180.00 ➝ $245.00 | Buy ➝ Buy | |
QUAD Quad/Graphics | Initiated by | Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.72 +2.6% | $7.50 | Buy | |
RARE Ultragenyx Pharmaceutical | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.14 +3.9% | $68.00 ➝ $72.00 | Outperform ➝ Outperform | |
RARE Ultragenyx Pharmaceutical | Target Raised by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.14 +3.9% | $107.00 ➝ $115.00 | Overweight ➝ Overweight | |
RARE Ultragenyx Pharmaceutical | Target Raised by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.14 +3.9% | $124.00 ➝ $127.00 | Buy ➝ Buy | |
RARE Ultragenyx Pharmaceutical | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.14 +3.9% | $83.00 ➝ $76.00 | Buy ➝ Buy | |
RARE Ultragenyx Pharmaceutical | Target Raised by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.14 +3.9% | $109.00 ➝ $111.00 | Buy ➝ Buy | |
RARE Ultragenyx Pharmaceutical | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.14 +3.9% | $47.00 ➝ $48.00 | Neutral ➝ Neutral | |
RBRK Rubrik | Initiated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | Y. Lee Subscribe to MarketBeat All Access for the recommendation accuracy rating | $30.48 +0.7% | $50.00 | Overweight | |
REE REE Automotive | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Dayal Subscribe to MarketBeat All Access for the recommendation accuracy rating | $4.32 -1.6% | $15.00 ➝ $15.00 | Buy ➝ Buy | |
REXR Rexford Industrial Realty | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.36 +1.5% | $52.00 ➝ $50.00 | Neutral ➝ Neutral | |
ROIV Roivant Sciences | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.36 -0.3% | $18.00 ➝ $18.00 | Buy ➝ Buy | |
RSVR Reservoir Media | Target Raised by | B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating | G. Boss Subscribe to MarketBeat All Access for the recommendation accuracy rating | $8.04 -2.8% | $11.00 ➝ $11.50 | Buy ➝ Buy | |
S SentinelOne | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.83 -13.3% | $29.00 ➝ $25.00 | Overweight ➝ Overweight | |
S SentinelOne | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.83 -13.3% | $35.00 ➝ $29.00 | Buy ➝ Buy | |
S SentinelOne | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.83 -13.3% | $33.00 ➝ $33.00 | Market Outperform ➝ Market Outperform | |
S SentinelOne | Target Lowered by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.83 -13.3% | $30.00 ➝ $23.00 | Buy ➝ Buy | |
S SentinelOne | Target Lowered by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.83 -13.3% | $35.00 ➝ $22.00 | Positive ➝ Positive | |
S SentinelOne | Target Lowered by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.83 -13.3% | $26.00 ➝ $19.00 | Equal Weight ➝ Equal Weight | |
S SentinelOne | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.83 -13.3% | $29.00 ➝ $27.00 | Buy ➝ Buy | |
S SentinelOne | Target Lowered by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.83 -13.3% | $31.00 ➝ $25.00 | Overweight ➝ Overweight | |
S SentinelOne | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.83 -13.3% | $27.00 ➝ $22.00 | Equal Weight ➝ Equal Weight | |
S SentinelOne | Target Lowered by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.83 -13.3% | $30.00 ➝ $25.00 | Buy ➝ Buy | |
SBCF Seacoast Banking Co. of Florida | Upgraded by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | W. Lay Subscribe to MarketBeat All Access for the recommendation accuracy rating | $23.67 +3.9% | $26.00 ➝ $27.00 | Market Perform ➝ Outperform | |
SCHW Charles Schwab | Target Lowered by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $73.28 +1.9% | $89.00 ➝ $81.00 | Overweight ➝ Overweight | |
SHAK Shake Shack | Reiterated by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.89 +0.6% | $125.00 ➝ $125.00 | Buy ➝ Buy | |
SLDB Solid Biosciences | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.26 +8.1% | $20.00 | Overweight | |
SLDB Solid Biosciences | Target Lowered by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.26 +8.1% | $12.00 ➝ $10.00 | Neutral ➝ Neutral | |
SLN Silence Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.99 -3.8% | $75.00 ➝ $75.00 | Buy ➝ Buy | |
SMMT Summit Therapeutics | Target Raised by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.69 -20.4% | $7.00 ➝ $13.00 | Buy ➝ Buy | |
SO Southern | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $80.14 +2.6% | $73.00 ➝ $79.00 | Neutral ➝ Neutral | |
SPTN SpartanNash | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.65 -0.9% | $22.00 ➝ $20.00 | Market Perform ➝ Market Perform | |
SRPT Sarepta Therapeutics | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $129.86 +4.3% | $157.00 | Overweight | |
STX Seagate Technology | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $93.24 -0.5% | $100.00 ➝ $110.00 | Buy ➝ Buy | |
SWTX SpringWorks Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.46 -2.7% | $74.00 ➝ $74.00 | Buy ➝ Buy | |
TBBB BBB Foods | Target Raised by | Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.24 +0.7% | $33.00 ➝ $36.00 | Sector Outperform ➝ Sector Outperform | |
UDR UDR | Target Raised by | Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.62 +2.0% | $39.00 ➝ $41.00 | Overweight ➝ Overweight | |
ULTA Ulta Beauty | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $395.09 +2.5% | $630.00 ➝ $500.00 | Outperform ➝ Outperform | |
ULTA Ulta Beauty | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $395.09 +2.5% | $505.00 ➝ $498.00 | Overweight ➝ Overweight | |
ULTA Ulta Beauty | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $395.09 +2.5% | $500.00 ➝ $500.00 | Outperform ➝ Outperform | |
ULTA Ulta Beauty | Target Lowered by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $395.09 +2.5% | $540.00 ➝ $500.00 | Market Perform ➝ Market Perform | |
ULTA Ulta Beauty | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $395.09 +2.5% | $530.00 ➝ $544.00 | Overweight ➝ Overweight | |
ULTA Ulta Beauty | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $395.09 +2.5% | $520.00 ➝ $500.00 | Buy ➝ Buy | |
UMBF UMB Financial | Upgraded by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Mcgratty Subscribe to MarketBeat All Access for the recommendation accuracy rating | $82.44 +2.0% | $93.00 ➝ $98.00 | Market Perform ➝ Outperform | |
UNCY Unicycive Therapeutics | Reiterated by | Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.88 +5.2% | $3.00 ➝ $3.00 | Speculative Buy ➝ Speculative Buy | |
VALN Valneva | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.07 +1.9% | $26.00 ➝ $26.00 | Buy ➝ Buy | |
VEEV Veeva Systems | Target Lowered by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $174.25 -10.3% | $235.00 ➝ $185.00 | Neutral ➝ Neutral | |
VEEV Veeva Systems | Target Lowered by | Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $174.25 -10.3% | $250.00 ➝ $210.00 | Buy ➝ Buy | |
VEEV Veeva Systems | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $174.25 -10.3% | $220.00 ➝ $210.00 | Hold ➝ Hold | |
VEEV Veeva Systems | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $174.25 -10.3% | $260.00 ➝ $260.00 | Buy ➝ Buy | |
VEEV Veeva Systems | Target Lowered by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $174.25 -10.3% | $245.00 ➝ $235.00 | Overweight ➝ Overweight | |
VEEV Veeva Systems | Target Lowered by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $174.25 -10.3% | $240.00 ➝ $204.00 | Neutral ➝ Neutral | |
VEEV Veeva Systems | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $174.25 -10.3% | $210.00 ➝ $173.00 | Underweight ➝ Underweight | |
VEEV Veeva Systems | Target Lowered by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | K. Materne Subscribe to MarketBeat All Access for the recommendation accuracy rating | $174.25 -10.3% | $230.00 ➝ $200.00 | In-Line ➝ In-Line | |
VEEV Veeva Systems | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $174.25 -10.3% | $245.00 ➝ $220.00 | Overweight ➝ Overweight | |
VERA Vera Therapeutics | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.99 +2.8% | $60.00 ➝ $65.00 | Overweight ➝ Overweight | |
VLY Valley National Bancorp | Reiterated by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Perito Subscribe to MarketBeat All Access for the recommendation accuracy rating | $7.13 +2.6% | $12.00 ➝ $8.00 | Outperform ➝ Market Perform | |
VRTX Vertex Pharmaceuticals | Target Raised by | BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $455.34 +2.8% | $480.00 ➝ $500.00 | Outperform ➝ Outperform | |
VSAT Viasat | Target Lowered by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.89 +2.4% | $30.00 ➝ $23.00 | Overweight ➝ Overweight | |
VSTS Vestis | Initiated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.32 +1.7% | | Market Perform | |
WBA Walgreens Boots Alliance | Target Lowered by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.22 +5.4% | $16.00 ➝ $13.00 | Underweight ➝ Underweight | |
WDC Western Digital | Target Raised by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.29 -0.3% | $80.00 ➝ $90.00 | Buy ➝ Buy | |
WHD Cactus | Downgraded by | Johnson Rice Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $51.35 +2.0% | | Buy ➝ Accumulate | |
WPC W. P. Carey | Initiated by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $56.40 +0.6% | $57.00 | Neutral | |
XERS Xeris Biopharma | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.26 +1.8% | $6.00 ➝ $6.00 | Buy ➝ Buy | |
XFOR X4 Pharmaceuticals | Reiterated by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.01 +3.5% | $5.00 ➝ $5.00 | Overweight ➝ Overweight | |
XOMA XOMA | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.79 +2.2% | $74.00 ➝ $74.00 | Buy ➝ Buy | |
XYL Xylem | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $141.02 +1.2% | $147.00 ➝ $152.00 | Outperform ➝ Outperform | |
ZBH Zimmer Biomet | Target Lowered by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $115.15 +0.6% | $130.00 ➝ $125.00 | Underweight ➝ Underweight | |
ZS Zscaler | Target Lowered by | Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $250.00 ➝ $210.00 | Sector Outperform ➝ Sector Outperform | |
ZS Zscaler | Target Lowered by | Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $225.00 ➝ $180.00 | Hold ➝ Hold | |
ZS Zscaler | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $205.00 ➝ $210.00 | Overweight ➝ Overweight | |
ZS Zscaler | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $290.00 ➝ $290.00 | Strong-Buy ➝ Strong-Buy | |
ZS Zscaler | Target Lowered by | Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $240.00 ➝ $220.00 | Buy ➝ Buy | |
ZS Zscaler | Reiterated by | JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $270.00 ➝ $270.00 | Market Outperform ➝ Market Outperform | |
ZS Zscaler | Target Raised by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $215.00 ➝ $230.00 | Outperform ➝ Outperform | |
ZS Zscaler | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $200.00 ➝ $205.00 | Neutral ➝ Neutral | |
ZS Zscaler | Target Lowered by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $258.00 ➝ $220.00 | Buy ➝ Buy | |
ZS Zscaler | Target Lowered by | Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $275.00 ➝ $210.00 | Positive ➝ Positive | |
ZS Zscaler | Target Lowered by | Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $280.00 ➝ $270.00 | Outperform ➝ Outperform | |
ZS Zscaler | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $169.96 +8.5% | $290.00 ➝ $260.00 | Outperform ➝ Outperform | |
ZS Zscaler | Target Lowered by | Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating | Y. Lee Subscribe to MarketBeat All Access for the recommendation accuracy rating | $169.96 +8.5% | $230.00 ➝ $200.00 | Neutral ➝ Neutral | |